Dan Liu
China Institute of Veterinary Drug Control(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, PARP inhibition in cancer therapy, SARS-CoV-2 and COVID-19 Research, Cancer-related molecular mechanisms research, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Machine learning based early warning system enables accurate mortality risk prediction for COVID-19(2020)357 cited
- → Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer(2019)251 cited
- → A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12(2013)148 cited
- → C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation(2018)130 cited
- → The patterns and timing of recurrence after curative resection for gastric cancer in China(2016)130 cited
- → MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1(2014)118 cited
- → Dysregulated expression of miR‐146a contributes to age‐related dysfunction of macrophages(2011)106 cited
- → Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer(2017)99 cited
- → SIX1 Promotes Tumor Lymphangiogenesis by Coordinating TGFβ Signals That Increase Expression of VEGF-C(2014)96 cited
- → Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study(2020)94 cited